{"pageContent": "Purpose: The expanded prostate cancer index composite-26 (EPIC-26) instrument is a validated research tool used for capturing patient-reported quality-of-life outcomes related to the domains of bowel, bladder, and sexual functioning for men undergoing curative treatment for prostate cancer. The purpose of this pilot study was to explore the perceptions and experiences of clinicians with using EPIC-26 in a clinical setting for patients receiving curative radiotherapy.", "metaData": {"source": "Communicating risk in active surveillance of localised prostate cancer: a protocol for a qualitative study\nhttps://pubmed.ncbi.nlm.nih.gov/28982830/"}}